首页 | 本学科首页   官方微博 | 高级检索  
     

Toll样受体与血液系统恶性肿瘤
引用本文:夏亮,王兴兵,吴竞生. Toll样受体与血液系统恶性肿瘤[J]. 国外医学:内科学分册, 2008, 35(12): 735-738
作者姓名:夏亮  王兴兵  吴竞生
作者单位:安徽医科大学附属省立医院血液科,安徽,合肥,230032;安徽医科大学附属省立医院血液科,安徽,合肥,230032;安徽医科大学附属省立医院血液科,安徽,合肥,230032
基金项目:国家自然科学基金  
摘    要:
Toll样受体(TLR)是近年来发现的一类天然免疫受体,在天然免疫及继发激活获得性免疫过程中均发挥非常重要的作用.对TLR的进一步深入研究表明,TLR在绝大多数血液系统恶性肿瘤中均有不同程度的表达,并且发挥一定生物学效应.这为我们提高血液系统恶性肿瘤的治疗效果,改善疾病的生存和预后提供了新的潜在治疗靶点.本文旨在对TLR与血液系统恶性肿瘤之间的关系及其所发挥的作用作一综述.

关 键 词:Toll样受体  血液系统恶性肿瘤  激动剂

The relationship between Toll-like receptor and hematological malignant tumor
XIA Liang,WANG Xing-bing,WU Jing-sheng. The relationship between Toll-like receptor and hematological malignant tumor[J]. Foreign Medical Sciences(Section of Internal Medicine), 2008, 35(12): 735-738
Authors:XIA Liang  WANG Xing-bing  WU Jing-sheng
Affiliation:XIA Liang,WANG Xing-bing,WU Jing-sheng.Department of Hematology,Anhui Provincial Hospital,Hefei 230032,China
Abstract:
Toll-like receptor(TLR) was a kind of receptor of natural immunity which was found within the past few years.TLR plays an important role in the process of natural immunity and secondarily activating acquired immunity.Further research revealed that TLR was expressed in most of hematological malignant tumors and led to some biological effects.It conferred us a potential target used to improve treatment effectiveness of tumors and ameliorate survival/ prognosis.This review was to summarize the function of TLR ...
Keywords:TLR  Hematological malignant tumors  Agonist.  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号